Optometry Times

A comprehensive eye exam is more than just a vision check; it’s a vital tool for early disease detection and overall eye health. Stay informed on the latest research, clinical insights, and expert perspectives with Optometry Times. Click here to explore our comprehensive eye exam coverage: https://hubs.li/Q03bLFGb0 #EyeExam #Optometry

"As eye care providers in an era of rapid therapeutic advancement, we must consider how formulation science shapes treatment outcomes in presbyopia management. This consideration becomes particularly crucial as presbyopia represents one of the most significant visual changes our patients will experience in their lifetime, often coinciding with their peak career and family responsibilities. The emergence of pharmacologic agents for refractive correction for presbyopia represents more than just a new treatment modality; it reflects a deeper understanding of how precise formulation can enhance both efficacy and patient experience while supporting increasingly demanding lifestyles," write Jacob R. Lang, OD, FAAO, and Jaclyn Garlich, OD, FAAO. Read more: https://lnkd.in/gKtN7dqw

Topcon Healthcare, RadiusXR, and Glaukos have announced a new collaboration and the launch of RadiusXR’s Inspire wearable vision testing platform. The collaboration will combine RadiusXR’s visual field platform, Topcon’s robotic diagnostics and digital healthcare solutions, and Glaukos’ expansion of “patient access by democratizing the diagnosis of ophthalmic diseases such as glaucoma” in order to expand access to and education on visual field exams for glaucoma patients, according to a news release. Read more: https://lnkd.in/e225ye2b

BREAKING: The FDA has accepted the New Drug Application (NDA) submitted by Sydnexis for SYD-101, a low-dose atropine drop indicated for myopia management, with a Prescription Drug User Fee Act (PDUFA) target action date set for October 23, 2025. If approved, the atropine drop will be the first and only pharmaceutical option for the treatment of progression of pediatric myopia in the United States. Read more: https://lnkd.in/eAcqBJfB

An international collaborative research effort found that with aging, a higher genetic risk score is a stronger predictor of elevated intraocular pressure (IOP) and an increased chance of developing glaucoma. The researchers, led by first author Jihye Kim, PhD, from the Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, published their findings in Investigative Ophthalmology and Visual Science. In their report, the authors explained, “The main reason why people go blind from glaucoma is because the disease has an insidious onset, and patients present too late. Genetic makeup is largely determined at birth. Thus, a properly timed recall-by-glaucoma polygenic risk score (PRS) approach might represent a viable screening strategy to facilitate early disease detection. The timing of such a prevention strategy must account for the age-related component of the disease and its fairly low incidence.” Read more: https://lnkd.in/eERM3e-M

In a recent webinar, The Vision Council gave an overview of some of the most significant implications that the latest round of tariff rollouts from the Trump administration has on the optical industry. The webinar was held on March 6, the same day that President Donald Trump signed executive actions that place tariffs on all products from Mexico and Canada covered by the USMCA free trade treaty on delay for nearly a month. If implemented, the tariffs would increase costs on a wide range of imported goods and materials necessary for eyewear manufacturing and distribution, according to The Vision Council’s news release. For Chinese-origin materials, a 20% duty tariff has been added (10% effective on February 5, 2025, with another 10% made effective on March 4, 2025) to the previously existing China 301 tariffs and regular duties, ranging from 7.5% to 25%. Some products also face duties as high as 50% to 100%, according to Rick Van Arnam, regulatory affairs counsel for The Vision Council. These tariffs have been imposed under the International Emergency Economic Powers Act due to concerns regarding fentanyl imports. Subsequently, China has retaliated with tariffs on US coal, liquefied natural gas, crude oil, agricultural machinery, cars, and key agricultural products, as well as export controls on critical metals. Read more: https://lnkd.in/dUegPnSp

Slogging through spring? Enjoy our weekly recap to put some pep back into your step: https://lnkd.in/epichCpn

On International Women's Day, we celebrate the innovations and achievements of women in optometry that are impacting the lives of patients and advancing the industry forward. #InternationalWomensDay #Optometry

The CRU Eye Symposium returns on March 28-30, 2025, at the Napa Valley Marriott Hotel & Spa! ???? Led by program chairs Dr. Stephanie Woo and Dr. John Gelles, this premier event delivers cutting-edge contact lens, glaucoma, anterior segment education and much more, along with valuable networking opportunities in the heart of wine country. ??? Earn COPE CE/CME & register now: https://ow.ly/tCk150VcXxp

At Vision Expo East 2025, a group of panelists presented new data released by the Contact Lens Institute (CLI) on purchase factors driving contact lens searches online. In the first installment of a 2-part Q&A, Charissa lee, OD, MBA, FAAO; Ryane Corte, OD; Roxanne Achong-Coan OD, FAAO, FIAOMC, FSLS, Dip CCLRT; and Nishan Pressley, OD share their insights in an exclusive interview with Optometry Times. Read Part 1: https://lnkd.in/eT9jucBd Read Part 2: https://lnkd.in/emSPgRyD